Nixon's Schedule I Was Based on Science
The claim that cannabis landed in Schedule I after careful scientific review collapses the moment you read the actual record.
Cannabis ended up in Schedule I in 1970 as a placeholder, not a verdict. Nixon's own hand-picked commission — the Shafer Commission — recommended decriminalization two years later. Nixon ignored it. The White House tapes show him talking about Jews, hippies, and political enemies, not pharmacology. Anyone telling you Schedule I reflects a sober scientific assessment of cannabis is either misinformed or selling something. The historical record is unusually clear on this one.
The claim
You hear it in congressional hearings, on cable news, and from prohibitionist advocacy groups: cannabis is in Schedule I of the Controlled Substances Act because scientists and doctors looked at the evidence in 1970 and concluded it had high abuse potential and no accepted medical use. The implication is that the schedule reflects pharmacology, not politics, and that anyone who wants to reschedule cannabis is asking the government to override science.
This story is wrong in almost every particular. The 1970 placement was explicitly temporary, the scientific review that was supposed to follow recommended the opposite of what happened, and the decision to keep cannabis in Schedule I was made by the President personally, against the advice of his own commission, for reasons he stated on tape.
What actually happened in 1970
The Controlled Substances Act passed in October 1970 [1]. During drafting, Assistant Secretary of Health Roger Egeberg wrote to Congress recommending cannabis be placed in Schedule I — but his letter explicitly said this was a holding position pending the report of a national commission [2]. Egeberg's letter reads: 'Since there is still a considerable void in our knowledge of the plant and effects of the active drug contained in it, our recommendation is that marihuana be retained within Schedule I at least until the completion of certain studies now underway.'
That commission was the National Commission on Marihuana and Drug Abuse, chaired by former Republican Governor of Pennsylvania Raymond P. Shafer. Nixon appointed Shafer personally and packed the commission with conservatives, expecting a report that would justify a hard line [3].
The commission spent two years reviewing the evidence. In March 1972 it published Marihuana: A Signal of Misunderstanding [4]. Its central recommendation: decriminalize personal possession and non-profit transfers of small amounts. It found that cannabis did not cause violence, did not lead inevitably to harder drugs, and did not justify the criminal penalties then in place.
Nixon's reaction, on tape
Nixon rejected the Shafer Commission's findings before they were published. The White House tapes, declassified and transcribed by historian Dan Baum and others, show Nixon discussing cannabis policy in terms that have nothing to do with pharmacology [5][6].
In a May 1971 conversation with Bob Haldeman, Nixon links marijuana to Jews and to communism, says 'every one of the bastards that are out for legalizing marijuana is Jewish,' and instructs Haldeman to make sure the commission comes out the right way [5]. He tells Shafer directly, in a recorded Oval Office meeting, that he wants a report supporting his existing position, regardless of what the evidence shows [6].
John Ehrlichman, Nixon's domestic policy chief, later told journalist Dan Baum that the drug war was designed as a political weapon: 'We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities' [7]. The Ehrlichman quote has been contested by his family, but it is consistent with what the tapes show Nixon saying in his own voice.
What 'no accepted medical use' actually meant
The Schedule I criteria require that a substance have 'no currently accepted medical use in treatment in the United States.' This is a regulatory finding, not a scientific one. It hinges on whether the FDA has approved a product — which historically required clinical trials that DEA scheduling itself made nearly impossible to conduct [8].
This circularity has been documented for decades. Researchers needed DEA approval and NIDA-supplied cannabis to run trials; trials were the only path to 'accepted medical use'; without 'accepted medical use,' the substance stayed in Schedule I; staying in Schedule I kept the research bottleneck in place. The FDA's 2024 review supporting rescheduling to Schedule III explicitly acknowledges that cannabis has accepted medical use under modern criteria [9].
Meanwhile, the United States government itself holds Patent 6,630,507 on cannabinoids as antioxidants and neuroprotectants, granted in 2003 [10]. It is difficult to argue a substance has 'no medical use' while simultaneously patenting its medical uses.
Where the 'based on science' story comes from
The claim that Schedule I reflects scientific consensus has two sources. The first is the DEA itself, which has repeatedly defended the schedule in court and in petitions for rescheduling by citing the legal criteria as if they were scientific findings [8]. The second is anti-legalization advocacy groups that cite the schedule as evidence of harm — a textbook circular argument, since the schedule was the policy decision in question.
The claim has survived because most people have never read the Shafer Report, do not know it exists, and assume that a 54-year-old federal classification must rest on something more substantial than a President's political instincts. It does not.
What to do instead
If you want to understand how cannabis got into Schedule I, read the actual primary sources: the Shafer Commission report [4], Egeberg's letter to Congress [2], and the Nixon tapes transcripts [5][6]. They are all public.
If someone tells you Schedule I is based on science, ask them which scientific body recommended it. The answer is: none. The placeholder was supposed to be reviewed by the Shafer Commission. The Shafer Commission recommended decriminalization. Nixon overruled it. Every subsequent administration has inherited that decision without revisiting the underlying evidence in any serious way until the HHS recommendation to reschedule in 2023 [9].
That does not, by itself, tell you what cannabis policy should be. Reasonable people disagree about scheduling, taxation, age limits, and advertising. But the disagreement should start from the actual history, not from the myth that a careful scientific process produced the current law.
Sources
- Government Controlled Substances Act, Pub. L. 91-513, 84 Stat. 1242 (October 27, 1970).
- Government Egeberg, R. O. Letter to Hon. Harley O. Staggers regarding marihuana scheduling, August 14, 1970. Reproduced in DEA scheduling petition records and NORML archives.
- Book Baum, Dan. Smoke and Mirrors: The War on Drugs and the Politics of Failure. Little, Brown, 1996.
- Government National Commission on Marihuana and Drug Abuse. Marihuana: A Signal of Misunderstanding. U.S. Government Printing Office, March 1972.
- Reported Frydl, Kathleen. 'Nixon Tapes Show Roots of Marijuana Prohibition: Misinformation, Culture Wars and Prejudice.' Common Sense for Drug Policy / CSDP archive, including primary tape transcripts from the Nixon Presidential Library.
- Reported Sharp, Gene. Transcripts of Nixon-Shafer Oval Office meeting, September 9, 1971. Nixon Presidential Library tape archives.
- Reported Baum, Dan. 'Legalize It All: How to win the war on drugs.' Harper's Magazine, April 2016.
- Peer-reviewed Nutt, D. J., King, L. A., & Nichols, D. E. (2013). Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews Neuroscience, 14(8), 577-585.
- Government U.S. Department of Health and Human Services. Basis for the Recommendation to Reschedule Marijuana into Schedule III of the Controlled Substances Act. August 2023 (released January 2024).
- Government Hampson, A. J., Axelrod, J., & Grimaldi, M. U.S. Patent 6,630,507: Cannabinoids as antioxidants and neuroprotectants. Assigned to the U.S. Department of Health and Human Services, granted October 7, 2003.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.